MedPath

Syndrome and Aspiration Pneumonia in Intensive Care

Completed
Conditions
ICU Patients
No Antibiotic Treatment
Under Mechanical Ventilation
In State of Coma (Define by Glasgow ≤ 8)
Registration Number
NCT01881672
Lead Sponsor
Centre Hospitalier Departemental Vendee
Brief Summary

Inhalation is a common condition in patients with impaired their awareness requiring protection of the upper airway by endotracheal intubation. This inhalation may lead to chemical pneumonitis and/or bacterial pneumonia. Only the latter requires the administration of antibiotics. Patients developing such a bacterial pneumonia, has a mortality, duration of mechanical ventilation and length of ICU stay increased. However, the proportion of patients with such bacterial pneumonia, bacterial ecology and morbidity that are little known.

The aim of this study is to determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Altered consciousness defined by a Glasgow Coma Scale score less than or equal to 8 before protection of the upper airway by endotracheal intubation
  • Patient under mechanical ventilation
Exclusion Criteria
  • Patient with pre-existing impairment of laryngeal function in Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, laryngeal cancer, radiotherapy laryngeal
  • Patient under guardianship
  • Inpatient without consent
  • Pregnant woman
  • Patient previously treated with antibiotics for more than 24 hours at the time of ICU admission
  • Patient with infection at ICU admission which justified probabilist antibiotic treatment
  • Lack of social security
  • Refusal of the patient or their next of kind

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilationICU Discharge

Participants will be followed for the duration of ICU stay, an expected average of 4 days

Secondary Outcome Measures
NameTimeMethod
Identification of predictive factors for development of bacterial pneumoniaICU Discharge

Participants will be followed for the duration of ICU stay, an expected average of 4 days

Description of the bacterial flora identified in respiratory specimens.ICU Discharge

Participants will be followed for the duration of ICU stay, an expected average of 4 days

Quantify the use of antibiotics during the ICU stay for patients admitted to the ICU for coma and treated with mechanical ventilationICU Discharge

Participants will be followed for the duration of ICU stay, an expected average of 4 days

Trial Locations

Locations (1)

CHD Vendee

🇫🇷

La Roche Sur Yon, France

© Copyright 2025. All Rights Reserved by MedPath